WORCESTER, Mass., Aug. 13 /PRNewswire-FirstCall/ -- Advanced Cell Technology, Inc., (OTC: ACTC) announced today that Dr. Robert Lanza, its Chief Scientific Officer, is featured on Deepak Chopra's Wellness Radio airing Saturday on Sirius/XM Stars, Channels 102 and 55 [Live Saturday 12 pm - 1 pm ET; Replays 1 pm - 4 am (Sunday) ET, and throughout the week]. The show focuses on Dr. Lanza's research at ACTC and his new book "Biocentrism." SIRIUS XM Stars Channel is the flagship satellite talk station featuring unique and diverse programs, including Deepak Chopra and broadcasting legend Barbara Walters, among others. It has a listenership of approximately 9 million people.
Chopra is a prolific author of over fifty-five books on topics ranging from health to consciousness and quantum mechanics, and was heralded by Time Magazine as one of the top heroes and icons of the century. On his show, Lanza discusses the cutting edge of regenerative medicine, including ACTC's efforts to use stem cells to treat blindness, vascular damage, and heart disease. ACTC hopes to file at least one application with the FDA this year to begin human clinical trials using retinal pigment epithelium (RPE) cells to treat macular degeneration and other retinal degenerative diseases.
Lanza and Chopra also discuss "Biocentrism," and how life and consciousness are the keys to understanding the true nature of the universe. "We think life is an accident of physics," explains Lanza. "But a long list of experiments suggests just the opposite. Amazingly, if you add life to the equation, you can explain some of the biggest puzzles of science. "
Deepak Chopra stated, "Having interviewed some of the most brilliant minds in the scientific world, I found Dr. Robert Lanza's insights into the nature of consciousness original and exciting. His theory of biocentrism is consistent with the most ancient wisdom traditions of the world which says that consciousness conceives, governs, and becomes a physical world. It is the ground of our Being in which both subjective and objective reality come into existence. I hope to have Dr. Lanza continue this conversation on Sirius XM satellite radio in the future."
"We believe that Dr. Lanza has contributed significantly to the understanding of the key role stem cells play in the field of regenerative medicine," said William M. Caldwell IV, Chairman and CEO of ACTC. "Through his scientific leadership the field is on the verge of therapeutically validating a new platform for regenerative medicine."
Click this link to listen to the Sirius/XM radio broadcast: http://www.sirius.com/siriusxmstars
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
|SOURCE Advanced Cell Technology, Inc.|
Copyright©2009 PR Newswire.
All rights reserved